Cautionary Statements This presentation is provided for general informational purposes only and it does not include every item which may be of interest, nor does it purport to present full and fair disclosure with respect to Atkore Inc. (the "Company" or "Atkore") or its operational and financial information. Atkore expressly disclaims any current intention to update any forward-looking statements contained in this presentation as a result of new information or future events or developments or otherwise, ex ...

Core Insights - Abbott reported strong financial results for Q4 2025, with total worldwide sales reaching $11.459 billion, a 4.4% increase from Q4 2024 [28] - The company achieved double-digit earnings per share growth, with adjusted diluted EPS of $1.50, reflecting a 12% increase [5] - Abbott's full-year 2025 sales totaled $44.328 billion, marking a 5.7% increase compared to 2024 [28] Financial Performance - Q4 2025 sales increased 4.4% on a reported basis and 3.0% on an organic basis, with a 3.8% increase when excluding COVID-19 testing-related sales [5][28] - Full-year 2025 GAAP diluted EPS was $3.72, while adjusted diluted EPS was $5.15, reflecting a 10% growth [5][28] - Abbott projects full-year 2026 organic sales growth to be in the range of 6.5% to 7.5% and adjusted diluted EPS of $5.55 to $5.80 [5][22] Segment Performance - In Q4 2025, Nutrition sales decreased by 8.9% on a reported basis and 9.1% on an organic basis, primarily due to lower sales volumes [9][10] - Diagnostics sales in Q4 2025 were $2.457 billion, a decrease of 2.5% on a reported basis and 3.6% on an organic basis [12][28] - Medical Devices sales increased by 12.3% on a reported basis and 10.4% on an organic basis, driven by strong growth in Electrophysiology and Diabetes Care [19][20] Strategic Developments - Abbott announced an agreement to acquire Exact Sciences, positioning the company to enter the cancer diagnostics market [5] - The company received FDA approval for its Volt™ PFA System and CE Mark for its TactiFlex™ Duo Ablation Catheter, enhancing its Electrophysiology portfolio [5][10] Dividend Information - Abbott declared a quarterly dividend of $0.63 per share, marking the 408th consecutive quarterly dividend and reflecting a commitment to returning value to shareholders [24]

Core Viewpoint - Simply Good Foods Company reported modestly better-than-expected financial performance for the first quarter of fiscal year 2026, reaffirming its full-year outlook and emphasizing its leadership in the nutritional snacking category, particularly with brands Quest and OWYN [2][3]. Financial Performance - Net sales for the first quarter were $340.2 million, a decrease of 0.3% compared to the same period last year, with Quest growing by 9.6% while Atkins and OWYN saw declines of 16.5% and 3.3% respectively [3][8]. - Gross profit was $109.9 million, down 15.8% year-over-year, with a gross margin of 32.3%, reflecting a 590 basis point decline due to elevated input costs [5][8]. - Operating expenses decreased by 4.7% to $72.3 million, with selling and marketing expenses down 10.1% [6][8]. - Net income was $25.3 million, a decrease of 33.7% from the previous year, with diluted earnings per share at $0.26 compared to $0.38 [7][9]. Market Trends and Brand Performance - Total retail takeaway for Simply Good Foods increased by approximately 1.8%, driven by Quest and OWYN's growth of 12.0% and 17.8% respectively, while Atkins declined by 19.3% [4]. - The company is focused on long-term growth, particularly for Quest and OWYN, and plans to increase marketing spending to support these brands [13][14]. Outlook and Strategic Initiatives - The company expects stronger performance in the second half of the fiscal year, with anticipated margin expansion and Adjusted EBITDA growth beginning in the third quarter [15][16]. - The company has increased its share repurchase program by $200 million, with approximately $224 million available under the revised program as of January 6, 2026 [12][11]. Balance Sheet and Cash Flow - As of the end of the first quarter, the company had cash of $194.1 million and a term loan balance of $400.0 million, resulting in a Net Debt to Adjusted EBITDA ratio of 0.8x [10][47]. - Cash flow from operations was approximately $50.1 million, an increase from $32.0 million in the comparable year-ago period, primarily due to improved working capital [10][36].

Financial Performance Highlights - Moody's achieved its second-highest Q2 revenue on record[9] - Moody's Analytics (MA) Annualized Recurring Revenue (ARR) reached $33 billion, an increase of 8% year-over-year[9] - Adjusted Operating Margin increased by 130 basis points to 509%[12] - Adjusted Diluted EPS increased by 9% to $356[12] Moody's Investors Service (MIS) Performance - MIS revenue outpaced issuance by approximately 12%[13] - MIS achieved an Adjusted Operating Margin of 642%, up 100 basis points[12, 16] - Total MIS rated issuance guidance was updated to reflect a decrease in the low-single-digit to mid-single-digit percent range[27, 36] Moody's Analytics (MA) Performance - MA experienced strong recurring revenue growth, with recurring revenue accounting for 96% of total revenue[19] - MA's Adjusted Operating Margin increased by 360 basis points to 321%[12, 19] - Decision Solutions led with 10% ARR growth[12] - MA revenue grew by 11% year-over-year[19] Updated Full Year 2025 Guidance - MCO revenue growth is projected to be in the mid-single-digit percent range[10] - Adjusted Diluted EPS is now expected to be in the range of $1350 to $1400[12] - The company plans to repurchase at least $13 billion in shares[39]

Core Viewpoint - Brady Corporation reported strong financial results for the third quarter of fiscal 2025, with significant sales growth driven by acquisitions and organic growth in the Americas and Asia regions, despite challenges from foreign currency translation [2][8]. Financial Results - Sales for the third quarter ended April 30, 2025, were $382.6 million, an increase of 11.4% from $343.4 million in the same quarter last year. This growth included organic sales growth of 1.6%, acquisition-related growth of 10.5%, and a decline of 0.7% due to foreign currency translation [2][4]. - For the nine-month period ended April 30, 2025, sales increased by 11.9% to $1.12 billion from $998.0 million in the same period last year, with organic growth of 2.6% and acquisition growth of 10.2% [5][7]. Income Metrics - Income before income taxes for the third quarter increased by 2.1% to $65.7 million compared to $64.4 million in the same quarter last year. Adjusted income before income taxes rose by 11.5% to $74.4 million [3][6]. - Net income for the third quarter was $52.3 million, up from $50.9 million in the same quarter last year. Adjusted net income increased to $58.8 million from $52.7 million [4][7]. Earnings Per Share - Earnings per diluted Class A Nonvoting Common Share for the third quarter was $1.09, compared to $1.05 in the same quarter last year, reflecting a 3.8% increase. Adjusted diluted EPS reached a record high of $1.22, up 11.9% from $1.09 [4][29]. Regional Performance - Sales in the Americas and Asia increased by 12.9%, with organic growth of 5.4%. In contrast, sales in Europe and Australia grew by 8.7%, but organic sales declined by 5.4% [2][5]. Shareholder Returns - The company returned $44.5 million to shareholders through dividends and share repurchases during the quarter, including repurchasing 476,000 shares for $33.2 million [8][9]. Fiscal Guidance - The company tightened its Adjusted Diluted EPS guidance for the fiscal year ending July 31, 2025, to a range of $4.48 to $4.63 per share, and updated GAAP earnings guidance to $3.95 to $4.10 per share [10][11].

Financial Performance - Revenue for Q1 2025 was $231.7 million, a decrease of 39% compared to Q1 2024[6, 10] - Gross margin in Q1 2025 was 25.1%, an increase of 560 bps compared to Q1 2024[6, 15] - Adjusted EBITDA for Q1 2025 was -$13 million, an improvement of $35 million compared to Q1 2024[6, 27] - Adjusted Diluted EPS for Q1 2025 was -$0.42, an increase of $0.80 compared to Q1 2024[6] - G&A and Tech Expense was $41 million, a decrease of $9 million or 18% compared to Q1 2024[6, 23] - Adjusted G&A and Tech Expense was $38 million, a decrease of $11 million or 22% compared to adjusted Q1 2024[23] Operational Metrics - Orders delivered (LTM) were 6.4 million, a decrease of 24.9% or 2.1 million compared to Q1 2024[32] - Average order value was $194, an increase of 12% compared to Q1 2024[32] - Active customers (LTM) were 4.8 million, a decrease of 20.9% or 1.3 million compared to Q1 2024[35] - Order frequency was 1.34, a decrease of 5.1% compared to Q1 2024[35]

Financial Highlights - Full year revenue reached a record of $123 billion[3] - Non-Pipeline revenues also reached a record level[3] - Total Backlog increased to $143 billion, a sequential increase of $440 million and a year-over-year growth of $19 billion[3] - Record FY Adjusted EBITDA increased 19% year-over-year, with margins improving 110 bps[3] - FY Adjusted EPS increased $214, or 118%, year-over-year[3] - Record Cash Flow from Operations reached $11 billion[3] Segment Results (2024) - Communications revenue was $346 billion[7] - Clean Energy and Infrastructure revenue was $2682 billion[7] - Power Delivery revenue was $4092 billion[7] - Pipeline Infrastructure revenue was $2134 billion[7] Q4 2024 Backlog - Total backlog reached $143 billion, up 15%, or $19 billion year-over-year, and $440 million, or 3% sequentially[11] - Clean Energy and Infrastructure backlog grew by ~$11 billion year-over-year to ~$42 billion[11] 2025 Guidance - Revenue is projected to be $1345 billion[19] - Adjusted EBITDA is expected to be between $11 billion and $115 billion[19] - Adjusted Diluted EPS is projected to be between $535 and $584[19] - Cash flow from operations is anticipated to approximate $700 million[24]